Drug re-purposing to improve outcomes in the management of prostate cancer – aims, outcome measures and design of current phase III trials
- DOI
- 10.1186/s40360-025-01077-w
- Published
- 2026-01-24
- Container
- BMC Pharmacology and Toxicology
- Publisher
- Springer Science and Business Media LLC
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1186/s40360-025-01077-w,
title = {Drug re-purposing to improve outcomes in the management of prostate cancer – aims, outcome measures and design of current phase III trials},
author = {Duncan C. Gilbert and Ruth E. Langley and Dami Ayadi and Mannab Berhanu and Lakshmi Kowdley Hemanth and Seunghee Kwon and Hossameldin Abdallah and Angela Meade and Noel Clarke and Silke Gillessen and Nicholas James and Gauthier Bouche and Mahesh Parmar and Matthew Nankivell and Laura Murphy},
year = {2026},
journal = {BMC Pharmacology and Toxicology},
doi = {10.1186/s40360-025-01077-w},
url = {https://doi.org/10.1186/s40360-025-01077-w}
}RIS
TY - JOUR TI - Drug re-purposing to improve outcomes in the management of prostate cancer – aims, outcome measures and design of current phase III trials AU - Duncan C. Gilbert AU - Ruth E. Langley AU - Dami Ayadi AU - Mannab Berhanu AU - Lakshmi Kowdley Hemanth AU - Seunghee Kwon AU - Hossameldin Abdallah AU - Angela Meade AU - Noel Clarke AU - Silke Gillessen AU - Nicholas James AU - Gauthier Bouche AU - Mahesh Parmar AU - Matthew Nankivell AU - Laura Murphy PY - 2026 JO - BMC Pharmacology and Toxicology DO - 10.1186/s40360-025-01077-w UR - https://doi.org/10.1186/s40360-025-01077-w ER -
APA
Gilbert, D. C., Langley, R. E., Ayadi, D., Berhanu, M., Hemanth, L. K., Kwon, S., Abdallah, H., Meade, A., Clarke, N., Gillessen, S., James, N., Bouche, G., Parmar, M., Nankivell, M., & Murphy, L. (2026). Drug re-purposing to improve outcomes in the management of prostate cancer – aims, outcome measures and design of current phase III trials. BMC Pharmacology and Toxicology. https://doi.org/10.1186/s40360-025-01077-w
Source records
- crossref · retrieved 2026-09-26T16:44:12.175Z